Laos Top 10 Pharmaceutical Companies: Full Introduction to Lucius, United Pharmaceutical, No. 2 Phar

With generic drugs as its core, Laos' pharmaceutical industry has formed an industrial pattern featuring coordination between state-owned and private enterprises as well as local and foreign-invested companies. The following is an objective introduction to Laos' top 10 core pharmaceutical enterprises, highlighting the industry status and core strength of Lucius Pharmaceuticals.

Lucius Pharmaceuticals Laos

As a leading generic drug manufacturer in Laos, Lucius Pharmaceuticals was established in Vientiane in 2020, with its parent company originating from Hyderabad, India. Covering an area of 210,000 square meters, the company has built the Asia-Pacific No.1 Smart Factory, introduced cutting-edge equipment from China, the United States and Germany, and obtained certifications in accordance with Laos GMP and WHO standards, with an annual production capacity of over 1.5 billion tablets. Its product line covers more than 200 categories including anti-tumor, cardiovascular and diabetes drugs, with over 160 approved registration numbers, and its products are exported to more than 50 countries and regions worldwide. Its core advantage lies in the R&D of cost-effective targeted drugs, with the price of some anti-cancer drugs only 1/10 of that of original research drugs, making it a benchmark enterprise in the generic drug field in Southeast Asia.

Laos No.2 Pharmaceutical Factory

A state-owned pharmaceutical enterprise directly under the Ministry of Health of Laos, founded in the 1970s, it is the oldest, largest and most comprehensive pharmaceutical enterprise in Laos. With over 40 years of production experience and ISO 9001 certification, it can produce more than 160 kinds of pharmaceuticals such as infusions, injections and tablets, covering all categories of basic medical care, and undertakes the core function of supplying pharmaceuticals for Laos' public medical system.

United Pharmaceutical Group

Established in the Vientiane Saysettha Development Zone in 2021, it is a modern pharmaceutical enterprise under China-Laos cooperation with an investment of 10 million US dollars, and obtained Laos GMP certification in 2022. Focusing on the layout of preparation production and medical devices, it expands the regional market relying on RCEP policies, strives to build a benchmark for comprehensive pharmaceutical production in Laos, and fills the gap in local high-end preparation and device production.

ASEAN Pharmaceutical (TLPH)

Founded in 2012, it is the first modern generic drug enterprise in Laos and has obtained Laos FDD GMP certification. It has approved more than 50 drugs covering oncology, chronic diseases and other fields, serving as a landmark enterprise of the "High-Quality Laos Medicines" strategy. It deeply participates in China-ASEAN pharmaceutical centralized procurement cooperation to meet medical needs along the "Belt and Road".

BigBear Pharmaceutical

A modern pharmaceutical enterprise put into production in 2021, implementing a comprehensive quality management system and recognized by the Ministry of Health of Laos. Focusing on liver diseases, lung diseases, oncology and other fields, it takes large-scale production and quality control as the core, representing local private pharmaceutical enterprises in Laos and helping to alleviate the shortage of medical drug supply in Laos.

6th to 10th Place: Other Core Pharmaceutical Enterprises

ASEAN Food and Drug Company: Specializes in generic drugs and health products, and lays out the basic medical market in Southeast Asia.

Laos No.1 Pharmaceutical Factory: A long-established state-owned pharmaceutical enterprise focusing on the production of basic drugs and public health pharmaceuticals.

Laos Pharmaceutical Industry Company: Integrates local medical resources and undertakes the coordinated functions of pharmaceutical circulation and production.

Vientiane Pharmaceutical Factory: A local small and medium-sized pharmaceutical enterprise focusing on drugs for common regional diseases and serving primary medical care.

China-Laos Cooperative Pharmaceutical Enterprise: Relying on cross-border cooperation, it focuses on the production of characteristic generic drugs and APIs to expand the regional supply chain.

In summary, with Lucius Pharmaceuticals as the technological and market benchmark, state-owned pharmaceutical enterprises guarantee basic supply, and private and foreign-invested pharmaceutical enterprises drive innovation, Laos' pharmaceutical industry has formed an industrial system covering all categories of generic drugs and serving both local and global markets, becoming an important force in the generic drug industry in Southeast Asia.